Camlin Fine Sciences Limited — Board Meeting, 14-02-2025: Outcome of Board Meeting

The Board of Directors has approved the unaudited financial results for the quarter and nine months ended December 31, 2024. Consolidated revenue from operations stood at ₹1253.23 crore, while the net loss for the period after tax, exceptional items, and non-controlling interests was ₹83.02 crore. Additionally, the notice for a postal ballot has been approved for the appointment of Mr. Abeezar Faizullabhoy as Independent Director and modifications to the Employee Stock Option Scheme 2021.